Richard Vaillancourt, PhD

Associate Professor, Pharmacology and Toxicology
BIO5 Institute Member

The cytoplasmic kinases that transmit the signal from the plasma membrane to various MAP kinase proteins include the MAP/Extracellular signal-regulated kinase (ERK) Kinase Kinase (MEKK) proteins. To date, at least four MEKK proteins have been identified based on a homology to similar protein kinases found in the budding yeast, Saccharomyces cerevisiae. However, the extracellular molecules that regulate the MEKK proteins remain largely undefined in mammalian cells. A major focus in the Vaillancourt laboratory is the characterization of MEKK4 in cellular signal transduction pathways.

Current research focuses on the regulation of MEKK4 by the growth factor, heregulin, which activates the HER2/HER3 receptor signaling pathway. Notably, activation of the HER2/HER3 pathway is critical in some forms of breast cancer thus implicating MEKK4 in breast cancer cell signaling. Activation of breast cancer cells with heregulin results in synthesis of lactate and extracellular secretion of lactate which creates a pH changed in the extracellular environment. Current students are investigating the role of extracellular lactate in breast cancer cell biology.

View UA Profile

Education & Post Graduate Training: 

BA, Biology, St. Anselm College (New Hampshire), 1984
PhD, Pharmacology, University of Wisconsin, Madison, 1992

Select Publications

2019

Garcia-Flores AE, Sollome JJ, Thavathiru E, Bower JL, Vaillancourt RR. "HER2/HER3 regulates lactate secretion and expression of lactate receptor mRNA through the MAP3K4 associated protein GIT1." Sci Rep. 2019;9(1):10823. PMCID: PMC6658559  PMID: 31346208